根據最新的財務報表(Form-10K),Fresenius SE & Co. KGaA 的總資產為 $0,淨利潤為 $1,264
FSNUY 的關鍵財務比率是什麼?
Fresenius SE & Co. KGaA 的流動比率為 0,淨利潤率為 5.52,每股銷售為 $40.53。
Fresenius SE & Co. KGaA 的收入按細分市場或地理位置如何劃分?
Fresenius SE & Co. KGaA 最大收入來源為 Fresenius Kabi,在最近的收益報告中收入為 8,612,000,000。就地區而言,North America 是 Fresenius SE & Co. KGaA 的主要市場,收入為 2,701,000,000。
Fresenius SE & Co. KGaA 是否盈利?
是的,根據最新的財務報表,Fresenius SE & Co. KGaA 的淨利潤為 $1,264
Fresenius SE & Co. KGaA 有負債嗎?
無,Fresenius SE & Co. KGaA 的負債為 0
Fresenius SE & Co. KGaA 的流通股有多少?
Fresenius SE & Co. KGaA 的總流通股為 0
關鍵數據
前收市價
$12.72
開盤價
$12.47
當日範圍
$12.45 - $12.66
52週區間
$9.78 - $33.93
交易量
24.7K
平均成交量
77.1K
股息收益率
--
每股盈餘 (TTM)
0.59
市值
$28.3B
什麼是 Fresenius SE & Co. KGaA?
Fresenius SE & Co. KGaA is a healthcare group, which engages in the provision of products and services for dialysis, hospitals, and outpatient medical care. The company is headquartered in Bad Homburg, Hessen. The firm has operationally managed divisions Fresenius Kabi and Fresenius Helios as well as the holdings Fresenius Vamed and Fresenius Medical Care. Fresenius Kabi offers healthcare products for critically and chronically ill patients and offers essential medicines and medical technology for infusion, transfusion and clinical nutrition and its product portfolio includes intravenously administered generic medicines, infusion therapies and clinical nutrition. Fresenius Helios is a private hospital operator that operates clinics, medical facilities, rehabilitation centers and others. Fresenius Vamed provides services for hospitals and other healthcare facilities such as prevention, construction, service and operational management. Fresenius Medical Care offers products and services along the dialysis value chain and is a supplier of dialysis products such as dialysis machines, dialyzers and associated disposable accessories.